← Back to Search

Positive Affect + Education for Type 1 Diabetes (T1D Trial)

N/A

Waitlist Available

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

T1D Trial Summary

This trial will test the effects of a positive psychology intervention aimed at treating diabetes distress and improving glycemic outcomes in adolescents with type 1 diabetes. The potential benefits include better glycemic control, improved self-management, and psychosocial outcomes.

Eligible Conditions

Type 1 Diabetes

T1D Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Glycemic Control (HbA1c)

Secondary outcome measures

Diabetes Distress

Diabetes Self-Care Behavior

Diabetes-Related Quality of Life

+4 more

T1D Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PA + EducationExperimental Treatment2 Interventions

Participants in the Positive Affect + Education group will complete a behavioral health contract and receive an educational packet. In addition, they will receive intervention components aimed at inducing positive affect.

Group II: EducationActive Control1 Intervention

Participants in the Education group will complete a behavioral health contract and will receive an educational packet.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Education

2017

N/A

~4770

Positive Affect + Education

2019

N/A

~400

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Children's National Research InstituteOTHER

210 Previous Clinical Trials

207,361 Total Patients Enrolled

Vanderbilt University Medical CenterLead Sponsor

856 Previous Clinical Trials

671,796 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly adults eligible to participate in the clinical trial?

"This study is limited to teenagers aged between 13 and 17, in line with the stipulated selection standards."

Answered by AI

Is there still space available for participants in this experiment?

"This clinical trial is not presently seeking new participants; the initial post was on December 17th 2019 and it was last revised on September 6th 2022. Nevertheless, there are currently 1264 other studies that still require patients to participate in research activities."

Answered by AI

Which demographic is eligible to participate in this study?

"The trial is seeking 400 adolescent diabetics aged between 13 and 17 years old to participate. All interested parties must meet the specified age range criteria."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Positive Psychology Intervention to Treat Diabetes Distress in Teens With Type 1 Diabetes

Sarah Jaser 2019. "Positive Psychology Intervention to Treat Diabetes Distress in Teens With Type 1 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03845465.